The FDA sent out "100 cease-and-desist letters" to brands in response to what it says is "deceptive" pharma advertising - ...

One of them is already a leader in the market for weight management drugs, and the other could join this field.

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo Nordisk has mandated a return to office work for all staff to speed up decision-making and improve market execution, ...

Working-age Americans who get health insurance through their job will see largest health insurance rate hikes since 2010.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...

In response to what it says is "deceptive" pharmaceutical ads, the FDA sent out "100 cease-and-desist letters" to brands - a move that could have massive impact on pharma's $7 billion U.S. national TV ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...